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Triggering an appropriate protective response against invading agents is crucial to
the effectiveness of human innate and adaptive immunity. Pathogen recognition and
elimination requires integration of a myriad of signals from many different immune cells.
For example, T cell functioning is not qualitatively, but quantitatively determined by
cellular and humoral signals. Tipping the balance of signals, such that one of these
is favored or gains advantage on another one, may impact the plasticity of T cells.
This may lead to switching their phenotypes and, ultimately, modulating the balance
between proliferating and memory T cells to sustain an appropriate immune response.
We hypothesize that, similar to other intracellular processes such as the cell cycle, the
process of T cell differentiation is the result of: (i) pleiotropy (pattern) and (ii) magnitude
(dosage/concentration) of input signals, as well as (iii) their timing and duration. That is, a
flexible, yet robust immune response upon recognition of the pathogen may result from
the integration of signals at the right dosage and timing. To investigate and understand
how system’s properties such as T cell plasticity and T cell-mediated robust response
arise from the interplay between these signals, the use of experimental toolboxes
that modulate immune proteins may be explored. Currently available methodologies
to engineer T cells and a recently devised strategy to measure protein dosage may be
employed to precisely determine, for example, the expression of transcription factors
responsible for T cell differentiation into various subtypes. Thus, the immune response
may be systematically investigated quantitatively. Here, we provide a perspective of how
pattern, dosage and timing of specific signals, called interleukins, may influence T cell
activation and differentiation during the course of the immune response. We further
propose that interleukins alone cannot explain the phenotype variability observed in T
cells. Specifically, we provide evidence that the dosage of intercellular components of
both the immune system and the cell cycle regulating cell proliferation may contribute
to T cell activation, differentiation, as well as T cell memory formation and maintenance.
Altogether, we envision that a qualitative (pattern) and quantitative (dosage) crosstalk
between the extracellular milieu and intracellular proteins leads to T cell plasticity and
robustness. The understanding of this complex interplay is crucial to predict and prevent
scenarios where tipping the balance of signals may be compromised, such as in
autoimmunity.
Keywords: cytokine dosage, cytokine activation timing, (memory) T cell differentiation, cell cycle, CDK, p27Kip1,
autoimmunity, MAmTOW
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INTRODUCTION
Selecting the appropriate responses against invading agents is
crucial to the effectiveness of the human immune system. It has
to be simultaneously flexible, i.e., able to recognize all possible
threats and robust to prevent a too vigorous or unnecessary
response. Its relevance is especially pronounced in individuals
exhibiting genetic or acquired immune deficiencies, which result
in extreme sensitivity to pathogen invasions that may lead to
severe pathology, or death.
The immune system can be divided in two sub-systems:
the innate, or non-specific immune system, and the adaptive
(acquired), or specific immune system. The former serves as a
quick-acting defense line that promptly identifies and eliminates
potentially harmful foreign or endogenous particles. It consists
of: (i) specialized cells, such as natural killer (NK) cells, a type of
cytotoxic lymphocytes that function similarly to cytotoxic T cells,
by rapidly responding to virus, infected cells, and phagocytes,
cells that ingest harmful foreign particles, and (ii) the humoral
complement system, which consists of macromolecules found in
extracellular fluids such as complement proteins and secreted
antibodies, and the interferon system present in all nucleated
cells, including the ones of the immune system.
Conversely, the adaptive immune system uniquely targets and
destroys invading pathogens and includes T and B lymphocytes.
T (thymus) cells are involved in cell-mediated immunity, whereas
B (bone marrow) cells are crucial for adaptive humoral immunity,
leading to the production of large amounts of antibodies. These
cells specifically recognize “non-self ” antigens during a process
known as antigen presentation mediated by antigen-presenting
cells (APCs), such as dendritic cells and macrophages. Upon a
pathogen attack, Th (helper) cells produce small molecules called
cytokines, among which chemokines and interleukins, whereas
Tc (cytotoxic) cells produce toxic granules that contain enzymes
which kill pathogen-infected cells. Beside specificity, adaptive
immunity also retains a memory of invading pathogens, for both
T cells and B cells, whereas innate immunity does not.
The adaptive immune system protects mammals from a
myriad of invading and potentially harmful agents such as
bacteria, viruses and toxins. Dendritic cells, macrophages and
other APCs transport encountered antigens to the thymus. Here,
the foreign molecules are processed by a set of T (thymus) cells
selected for recognizing a specific non-self antigen. If a successful
match occurs, the antigen (together with other stimulatory
factors present on and secreted by the APC) will lead to activation
and proliferation of T cells with the corresponding specificity.
A naïve precursor T cell, also indicated as Th0 cell, is a
T cell that has successfully undergone the selection process
(licensing) in the thymus. Naïve T cells may differentiate into
several lineages, based on the selection and shaping of an
immune response most appropriate for the invading agent.
T cell activation can occur by recognition of a single antigen
independent of its maturation and differentiation state. Further,
T cell activation depends on (i) the nature of the presented
antigen, (ii) the presence and abundance of small proteins called
cytokines (e.g., chemokines and interleukins), and (iii) APC-
costimulatory signals, (Huang et al., 2013; Wertek and Xu, 2014).
After activation, T cell differentiation into one of the various
lineages is thought to result from the strength, duration and ratio
of extracellular stimuli transmitted through the T cell receptor
(TCR), which is responsible for the recognition of the presented
antigen (Tubo and Jenkins, 2014), and through a number of other
receptors sensing the cytokines.
To unveil the protective potential of a T cell fully, its mere
activation is not enough. Secondary proliferative signals are also
required for a T cell to become fully engaged. Proliferation
upon antigen recognition is mainly initiated by co-stimulation
of CD28 (Cluster of Differentiation 28), expressed on the T cell
surface, which is required for T cell survival. The co-stimulatory
signals provided by CD28 lead to the production of T cell clones
capable of recognizing the invading agent with high affinity and
specificity (Boomer and Green, 2010; Esensten et al., 2016). As
the added activation/proliferation signal is stronger in T cells with
their TCR actively engaged, a bias is created toward survival of the
T cells with the strongest affinity to the antigen. In Figure 1A, the
intracellular signaling cascades triggered upon TCR activation
and CD28 stimulation are illustrated as two separate pathways,
although crosstalk between these pathways exists. In the figure,
examples of this crosstalk have been highlighted by green arrows.
Stimulation of CD28 leads to PI3K activation, as well as of several
regulators of cell cycle progression, which in turn reinforces
the strength of the TCR signaling cascade by further promoting
stimulation of the Nuclear transcription Factor kappaB (NF-κB)
(Beyersdorf et al., 2015). This regulates the expression of genes
involved in inflammation and cell survival. Moreover, cyclin-
dependent kinases (CDKs) have a role in the balance between
T cell activation and anergy – “a tolerance mechanism in
which a lymphocyte is functionally inactivated following the
contact with an antigen, but remains alive for an extended
period of time in a hyporesponsive state” (Schwartz, 2003).
Specifically, CDK4 phosphorylates and enhances the activity of
the AP-1 family of proteins (Vanden Bush and Bishop, 2011),
which is critical in transcriptional regulation of T cells (see
Li et al., 2014, for a recent review). Furthermore, CDK2 is
necessary for normal T cell differentiation, as CDK2-deficient
T cells exhibit an anergic state, even if CD28 co-stimulation is
present (Chunder et al., 2012). Thus, T cell proliferative signals
are essential for T cell survival, and reinforced by coupling
cell cycle events occurring upon CD28 stimulation with TCR
activation.
The (added) strength of both CD28 and TCR signals may
have several consequences based on the modulation of the
CD28/TCR balance: (i) the T cell will undergo proliferation
when CD28 is activated together with TCR; (ii) the T cell will
undergo anergy when CD28 is not activated, although TCR is
fully active. In the former scenario, the T cell will develop into
the so called T helper (Th) cells that express on their surface
the glycoproteins CD4 (Cluster of Differentiation 4) or exhibit
cytotoxicity when carrying CD8 (Cluster of Differentiation 8).
After maturation of T cells, these may become CD4+ (helper,
Th) or CD8+ (cytotoxic, Tc) lineage of T cells (Germain, 2002),
also known as effector T cells. CD4+ T cells recognize antigens
presented on MHC (Major Histocompatibility Complex) class
II molecules by APCs, such as dendritic cells, and regulate the
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FIGURE 1 | T cell fate upon TCR activation and CD28 stimulation. (A) Successful activation of a T cell occurs through the TCR signaling cascade and CD28
co-stimulation. Stimulation of both TCR and CD28 results in T cell activation (left), whereas stimulation of TCR without CD28 co-stimulation results in T-cell anergy
(right). (B) T cells constantly integrate lineage-specific extracellular signals; the strongest signals eventually dictate a definite lineage a T cell will be committed to, in a
tug-of-war game (upper). This balance is dictated by a trade-off-weight of lineage-specific transcription factors. For example, differentiation of Th cells into Th1 or Th2
phenotypes is decided when either GATA-3 (Th2) or T-bet (Th1) is expressed (lower). Which of these transcription factors is expressed is the result of tipping the
balance between factors that function upstream in the TCR and CD28 signaling cascades. The amount of these factors is dependent on the strength of TCR- and
CD28-mediated stimulation upon antigen recognition. (C) Functional T cells are characterized by the T cell receptor (TCR), co-receptor CD3 and CD28
co-stimulation (upper). T cells can be activated and differentiated in vitro by crosslinking the TCR with CD3 antibodies and PMA treatment. Additionally, CD28 can be
triggered by antibodies directed against it, mimicking APC stimulation. The activation/proliferation status can be monitored by single-cell analysis of lineage-specific
transcription factors and DNA synthesis.
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immune response by releasing specific cytokines. Conversely,
CD8+ T cells recognize antigens presented on MHC-class-I
molecules, and release cytotoxic molecules, such as perforins, that
compromise membrane integrity and/or enter the cytoplasm of
damaged (cancer, infected) cells triggering apoptosis.
How the activation and balance of TCR and CD28 pathways
contribute quantitatively to T cell activation and lineage decision
has not been conclusively investigated in in vivo settings.
Furthermore, in vitro experiments have to rely on administration
of activating reagents and/or stimuli, or inhibitory agents (e.g.,
the PI3K inhibitor Wortmannin) to stimulate the activity of
intracellular factors. For example, T cell differentiation protocols
rely on specific antibodies as stimuli for TCR and/or CD28 for
either a limited temporal window or throughout the entire course
of the experiment (Avni et al., 2002; Flaherty and Reynolds, 2015).
Therefore, setting the level of activation is the result of stability,
availability, and concentration of multiple reagents/antibodies.
Upon stimulation of TCR and CD28, the respective
downstream signaling cascades are activated in a process for a T
cell to proliferate. However, any perturbation in the amounts of
the cytokines responsible for TCR and CD28 activation may tip
the balance shown in Figure 1A from T cell activation to anergy.
For this delicate balance to hold, thereby for T cell proliferation
to occur, cytokines produced in the environment shall be present
at definite levels and ratios. Although the type and abundance
of cytokines have been shown to induce specific T cell fates
(Rowbottom et al., 1999; Jones, 2005; Kimura and Kishimoto,
2010; Read et al., 2016; Eizenberg-Magar et al., 2017; Kaartinen
et al., 2017), precise levels at which cytokines are required have
not been determined yet.
Recently, we have devised a methodology to determine
quantitatively the effects of gene dosage, thereby protein
concentration, on in vivo cellular integrity, providing a detailed
example for the eukaryotic cell cycle (Barberis and Verbruggen,
2017). This methodology, which we coined “Maximum Allowable
mammalian Trade-Off-Weight” (MAmTOW), relies on gene
engineering strategies, such as the CRISPR/Cas9 technology,
and may be combined with optogenetic tools that enable –
upon light induction – the nuclear import and export of tagged
proteins. The goal of the methodology is to achieve a precise
measurement of upper limit gene copy number (gene dosage)
and microscopy-based visualization of protein spatiotemporal
localization. Integrating this output with computer models
provides information on cellular robustness (Barberis and
Verbruggen, 2017). Here, we propose that genetic engineering
technologies such as the MAmTOW may also be successfully
employed to investigate the weight of individual cytokines as well
as components of TCR and CD28 pathways to tip the balance that
modulates T cell activation, lineage decision and plasticity.
CYTOKINE PATTERN AND DOSAGE
DETERMINE T CELL DIFFERENTIATION
The fate of T cells relies on TCR activation and on the presence
and abundance of specific cytokines. Several studies have shown
that the concentration of a single cytokine, for instance an
interleukin, can influence the outcome of T cell activation and
proliferation in vitro. For example, IL-10 inhibits the activation
of CD8+ T cells in a dose-dependent manner (Rowbottom
et al., 1999). By way of another example, IL-6 modulates the
balance between regulatory T cells (also indicated as Treg) and T
helper 17 cells (also indicated as Th17), which are CD4+ T cells
involved in the prevention and (pro-inflammatory) induction
of autoimmune diseases, such as rheumatoid arthritis. In this
context, IL-6 promotes Th17 development from a naïve T cell,
but inhibits Treg differentiation (Kimura and Kishimoto, 2010).
Low IL-2 concentrations favor the formation and proliferation of
memory T cells (Kaartinen et al., 2017), as well as modulating
the balance between Treg and Th17. The disruption of this
balance is characteristic of autoimmune diseases (Kosmaczewska,
2014). Interestingly, IL-6 and IL-2 are crucial proliferation and
differentiation stimuli, and their effects are both pleiotropic and
ambiguous depending on their abundance, ratio and T cell type
they act upon (Jones, 2005; Read et al., 2016). Altogether, this
evidence indicates that it is not the presence or absence of specific
cytokines that determines the fate of T cells, but their precise
dosage (concentration). To understand the relevance of cytokines
for T cell differentiation, qualitative information is therefore
insufficient, whereas quantitative information of cytokine action
is desired.
The mode(s) of action of cytokines is (are) highly context-
(and timing-) dependent. For example, as compared to the T cells
that actively respond to a stimulus and induce some changes in
the immune response, memory T cells have encountered, and
responded to, their cognate antigen during a prior exposure to
a pathogen. When a second exposure occurs, memory T cells
recognize the invaders and initiate a much faster and stronger
immune response as compared to their naïve counterparts. For
example, the timing of stimulation of the first generation of
primary memory CD8+ T cells increases the responsiveness of
the second generation of memory CD8+ T cells (Khan et al.,
2015).
In a recent publication by Eizenberg-Magar et al. (2017),
a large repertoire of input cytokines was tested to investigate
differentiation of CD4+ T cells. By measuring the expression
of four important lineage-specifying transcription factors, i.e.,
GATA-3, T-bet, Foxp3, and RORγt as a function of the type
of input cytokines administered, the study has revealed that
a number of varied input cytokine combinations determines
CD4+ T cell differentiation. Strikingly, CD4+ T cells do not just
exhibit the discrete canonical phenotypes described in literature,
but also show a wide range of intermediate differentiation
states (Eizenberg-Magar et al., 2017). However, this work
considers different cytokine patterns and does not investigate
the importance of the interleukin concentrations relative to each
other, for the occurrence of these intermediate phenotypes.
Here, we propose that both a relative interleukin dosage and
a discrete interleukin pattern may specify the appearance of T
cell phenotypes. Currently, it is a challenge to investigate the
interplay, both qualitative (pattern) and quantitative (dosage),
between the interleukins required for T cell differentiation, both
in vitro and in vivo. This is because the interplay appears to be
dependent on a number of variables difficult to control, such
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as the stochastic expression of the TCR and cytokine receptors,
leading to cell-to-cell variability in the strength of the received
signal(s).
In such a precision-exalting scenario, a systems biology
analysis may provide support to understand the complex
dynamics underlying T cell differentiation. Specifically, to
investigate the formation of all possible T cell phenotypes at a
systems level, integration of high-quality and, most importantly,
precise experimental analyses, such those presented by Eizenberg-
Magar et al. (2017), with sophisticated computer models is of
vital importance. Computer models of T cell differentiation can
yield predictions on the specific phenotypic lineage decision
by varying the pattern and/or dosage of cytokines – including,
but not limited to, interleukins – which can be tested
experimentally.
While a number of computer modeling approaches are
available, T cell differentiation has been investigated by
employing at least three complementary strategies. First, the
model of Eizenberg-Magar et al. (2017) is considered as a
“black box,” and represented as a linear regression model. This
model was used to characterize the input–output relationships
between the patterns of T cell stimuli and the production
of their characteristic cytokines. While the construction and
analysis of such statistical models can be efficient, regulatory
information about the components of the biochemical networks
that mediate the T cell differentiation process is lacking.
Hence, these approaches are unable to be employed to further
investigate molecular mechanisms driving the process. This is
where mechanistic computational models become useful. Such
models take into account the specific (and detailed) mechanisms
of regulation of the components (genes, proteins, regulatory
molecules, etc.) considered. These models can be represented
with a plethora of mathematical approaches (many are reviewed
in Le Novère, 2015), including kinetic, or Ordinary Differential
Equations (ODEs), and logical modeling, which have been
applied to address T cell differentiation.
Kinetic models offer the advantage to incorporate specific
kinetic parameters (known and/or estimated) to represent
dynamics of components. For example, an ODE model of Carbo
et al. (2013) is generated to simulate T cell differentiation to
predict, and subsequently validate in vivo, the role of peroxisome
proliferator-activated receptor-gamma (PPARγ) as a modulator
of the switch between Th17 and inducible Treg phenotypes. In
another study, the same authors have developed an ODE model
to predict and provide basis for an in vivo validation that IL-21
regulates Th1 and Th17 responses during chronic Helicobacter
pylori infection (Carbo et al., 2014b). On the other hand, logical
models provide a (kinetic) parameter-independent approach to
address the dynamics of (large-scale) models. These have been
employed to investigate the regulatory network controlling the
differentiation of Th cells (Mendoza, 2006), as well as plasticity
of differentiated CD4+ T cells (Naldi et al., 2010; Abou-Jaoudé
et al., 2015; Martinez-Sanchez et al., 2015). Computational
modeling has helped to advance the understanding of CD4+
T cell plasticity and function, and existing as well as novel
computational strategies have been recently summarized (Carbo
et al., 2014a).
To aid the generation, validation and refinement of such
computer models, here, we propose a strategy to retrieve
quantitative information on immune response progression.
Importantly, we hypothesize that, similar to other intracellular
processes such as the cell cycle, the process of T cell differentiation
is the result of: (i) pleiotropy (pattern) and (ii) magnitude
(dosage/concentration) of input signals, as well as (iii) timing and
duration of their emergence and stability. We will first develop
these concepts on the activation of CD4+ T cells and their
subsequent proliferation and differentiation. Subsequently, we
will speculate about possibilities to investigate their development
into memory T cells. Finally, we will envision a strategy to
investigate how components of the signaling cascade leading
to the immune response and those of cell cycle progression
may crosstalk to impact timing of the immune response.
To rationalize the latter point, we will propose dedicated
experiments, based on genetic engineering technologies, to alter
the dosage of a pivotal cell cycle timer, the CDK inhibitor p27Kip1
(p27), and the CD28 cytokine receptor.
A REQUIREMENT OF
DOSE-DEPENDENT STIMULI FOR
T HELPER CELL DECISION MAKING
Cluster of Differentiation 3 (CD3) is a TCR co-receptor and
contributes to the activation of CD4+/CD8+ T cells. Cross-
linking of TCR by anti-CD3 antibodies (TCR/CD3 stimulation)
elicits a strong activation of downstream intracellular signaling
cascades (Dave, 2009; Smith-Garvin et al., 2009). Together with
TCR/CD3 dimerization, CD28 is also required for T cell survival,
and absence of CD28 co-stimulation results in T cells to remain
in an anti-proliferative, or anergic, state (Figure 1A).
CD4+ T cells mainly differentiate to T helper (Th) cells. These
contribute to the immune response by helping maturation of
B cells into plasma cells and memory B cells, as well as by
activating CD8+ T cells, or cytotoxic (Tc) cells. Depending on
the nature of stimulatory signals encountered, naïve CD4+ T
cells can differentiate into any of a number of phenotypes, such
as Th1, Th2, Th17, and Treg cells (O’Shea and Paul, 2010; Zhu
et al., 2010). Once fully activated, these cells divide rapidly and
secrete different cytokines that regulate different types of immune
responses. The major phenotypes into which naïve CD4+ T cell
differentiate are Th1 and Th2, which serve as effectors against
intracellular and extracellular invaders, respectively. The balance
between these two cell types may be monitored through the
relative abundance of two lineage-specific transcription factors:
T-bet (leading to the Th1 phenotype) and GATA-3 (leading to
the Th2 phenotype) (Murphy and Stockinger, 2010). Absence
of any of these two transcription factors, due to the absence of
the CD28 co-stimulatory signal, does identify non-responding,
anergic cells.
Triggering of the CD28 co-receptor in either absence of a
TCR ligand or presence of a weak ligand stimulating the TCR
yields a predominant Th2 phenotype. Conversely, a strong TCR
stimulation with a reduced (but not absent) CD28 stimulus
results in a Th1 phenotype (Figure 1B) (Riha and Rudd, 2010).
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A method to selectively trigger a Th1 or Th2-specific response
in vitro has been described (Smeets et al., 2012), which relies on
stimulation of cells with Phorbol 12-myristate 13-acetate (PMA)
and antibodies specific to either CD3 or CD28. Stimulation
with PMA/CD3 antibodies triggers a Th1 response, whereas
stimulation with PMA/CD28 yields a Th2 response. Considering
that in neither case both stimuli shall be present, a significant
fraction of treated cells will remain non-responsive or become
anergic. The stimulation scheme and the possible outcomes are
displayed in Figure 1C. By measuring the expression level of
Th1/Th2 lineage-specific transcription factors and BrdU/EdU
incorporation, the differentiation and proliferation state may be
determined.
Within this scenario, an interesting aspect is represented by
the non-anergic T cell population. Why is a small fraction of cells
activated, whereas the large majority is not? The question cannot
be satisfactorily answered by considering exclusively external
factors as, in principle, one triggering event is sufficient for T
cell activation. Furthermore, memory T cells respond faster to
antigen recognition as compared to naïve T cells, thus reinforcing
the idea that extracellular stimuli cannot be the only signals
responsible for differences in the pattern of phenotypes appearing
upon T cell activation (Cuddapah et al., 2010). For example,
poised RNA polymerase II has been suggested to control fast
induction kinetics of several cytokines, and to contribute to the
swift response capacity of memory T cells, putatively explaining
fast response of one T cell phenotype but not others (Adelman
et al., 2009; Cuddapah et al., 2010). Furthermore, cell-to-cell
variability upon naïve T cell activation may be explained by
chromatin permissibility for transcription of definite activation
regulators (Mariani et al., 2010). These mechanisms have been
described for specific subtypes of T cells, and may be employed
by the immune system to fine-tune the quality of the response
upon encountering an antigen. However, a general control system
that may rationalize the consequential appearance of the various
T cell phenotypes – if at all existing – has not been elucidated
yet.
Here, we propose that a less specific, yet effective dynamic
regulation may be in place to control the pattern of T cell
phenotypes, which is directly dependent on the timing at which
such phenotypes appear upon T cell activation. That is, variability
in the abundance of both TCR and CD28 signaling cascades may
play a role in T cell activation and differentiation dynamics, as
well as in the timing of the immune response upon recognition
of the invader. Example of targets that are activated upon TCR-
and CD28-mediated stimulations, and that may be tested for
their relevance in T cell differentiation dynamics, are the ZAP/70
kinase and its substrates, LAT adaptor (membrane-bound) and
SLP-76 adaptor (soluble) proteins, downstream the TCR cascade
(Pennock et al., 2013; Ngoenkam et al., 2017), as well as the PI3K
kinase and the IP3 secondary messenger molecule downstream
the CD28 cascade (Bjørgo and Taskén, 2010). Understanding of
the relevance of dosage and timing of input signal for T cell
activation and differentiation can be nowadays experimentally
investigated by CRISPR/Cas9-based approaches such as the
methodology that we have recently envisioned (Barberis and
Verbruggen, 2017).
A recent paper describes how TCR signaling can be studied
by CRISPR/Cas-9 technology in immortalized Jurkat T cells (Chi
et al., 2016). We provide here an example of how this technology
can be of use based on a modification of our earlier devised
MAmTOW strategy applied to these cells. This strategy uniquely
describes the functioning of a synthetic cassette – consisting
of a tetracycline repressor and a reported gene unit encoding
a fluorescent protein (e.g., GFP) – integrated into the genome
of mammalian cell lines, such as Jurkat T cells, which replaces
the endogenous promoter of a target gene to allow for its
tunable expression and quantification (Barberis and Verbruggen,
2017). Combining CRISPR/Cas-9 and MAmTOW systems would
enable the replacement of components of the endogenous T
cell signaling by tunable, engineered ones. Specifically, the
aforementioned synthetic cassette may be engineered in Jurkat
T cells, with the replacement alleles containing (i) an inducible
tetracycline promoter that allows for a tunable expression of
components, and (ii) a fluorescent tag to allow for an easy and
high-throughput screening of their abundance (dosage). Thus, by
adding tetracycline, the dosage of signaling components of choice
can be modulated, and the (upper and lower) thresholds required
for T cell activation and differentiation may be established
quantitatively.
Through such as strategy, the experiments performed in the
work of Eizenberg-Magar et al. (2017), where combinations
of input cytokines result in the formation of a pattern of
different CD4+ T cell phenotypes, may be conducted at a
large scale by testing a number of signaling molecules by
combining CRISPR/Cas-9 and MAmTOW methodologies.
That is, by engineering T cells, the differentiation path as a
function of both interleukin pattern/dosage and dosage of
intracellular components may be determined. Thus, the effects
of triggering TCR and CD28 simultaneously, or separately, may
be investigated (Figure 1C, bottom left). By quantitative
immunostaining or tagging of the transcription factors
responsible for the differentiation state of T cells, e.g., T-bet
and GATA-3, their expression can be concomitantly monitored
to investigate T cell’s lineage commitment (Figure 1C, bottom
right). Interestingly, a systems biology approach that integrates
computer modeling and single-cell measurements was able to
reveal that endogenous variation in the expression levels of
signaling proteins affects antigen responsiveness during T cell
activation, thereby influencing the phenotypic variability of cells
(Feinerman et al., 2008). Hence, it is plausible to envision that
a variable dosage of extracellular as well as intracellular stimuli
influences T cell differentiation, thereby inducing the pattern of
phenotypes that appear during the lineage decision process.
In the following sections, we will further elaborate on the
relevance of determining dosage, expression limits and timing
of intracellular signals upon TCR activation. We will rationalize
possible scenarios of tipping the balance among signals, such
that one of these may be favored or gains advantage on another
one, and how they can be crucial to understand the underlying
fundamentals of T cell activation and differentiation versus
anergy. A comparison of those scenarios with an emphasis on T
cell plasticity and reversibility of T cell differentiation phenotypes
will be also presented. Lastly, we will propose a strategy to
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investigate memory T cell formation quantitatively, and suggest
possible links between T cell differentiation and expression of cell
cycle regulators.
PRECISE CYTOKINE DOSAGE AND
ACTIVATION TIMING IMPACT
T CELL LINEAGE DECISION
It is currently not understood how the cytokine pattern influences
T cell fate both quantitatively (dosage) and temporally (over
time). This paradigm has been not addressed yet in the field;
however, the fundaments have been set by recent data showing
that combining various cytokines resulted in the formation of
a pattern of CD4+ T cell phenotypes (Eizenberg-Magar et al.,
2017).
During the course of an immune response the amount of
cytokines may vary for several reasons, such as for example
antigen level, efficiency of antigen recognition by the T cells,
or the number of T cells activated. Thus, we envision that
definite cytokines produced during the immune response may
be required in precise amounts, in order for a specific T cell
phenotype to appear over time. Furthermore, we predict that
the specific time at which cytokines are produced during the
immune response determines the timing at which a T cell
phenotype appears. A specific cytokine pattern may not suffice to
promote a T cell response if the amount and ratio of cytokines
are not appropriate. Hence, we propose that both individual
cytokine dosage and relative dosage as well as their timing of
activity, together with the cytokine pattern, are required for the
appearance of a specific T cell phenotype at a definite timing. In
support to this concept, it has been shown that the timing post-
infection of the cytokine type I interferon (IFN) administration
to CD8+ T cells with respect to TCR engagement by an antigen
determines whether a T cell is either activated or triggered toward
apoptosis (Crouse et al., 2015). This may be a concept that could
be generalized also for the CD4+ T cell lineage differentiation.
The cytokine patterns required to generate the various
canonical T cell phenotypes from a naïve CD4+ T cell are
relatively well characterized. For example, the major phenotypes
of T cell differentiation, Th1 and Th2, are triggered by IL-12
and IFNγ (Th1), and by IL-4 (Th2) abundance, respectively
(Figure 2A). It may be possible to investigate whether the
pattern of cytokines stimulating or produced by Th1 cells
would be able to influence the Th2 lineage when these are
introduced in in vitro cultures. In this scenario, conditioned
supernatants derived from both Th1 and Th2 cells may be mixed
in different ratios and added to a freshly activated naïve T
cell at different times, in order to investigate the proliferative
capacity and influence on the T cell lineage of specific cytokines
(Figure 2B). Furthermore, a complementary scenario may be
explored. Specifically, it can be investigated whether a definite
lineage, for example a Th2-differentiated cell, would be able
to revert its phenotype, becoming a Th1 cell upon expression
of a variable dosage, and of variable timing of activity, of the
cytokines that stimulate the appearance of the Th1 lineage. This
plasticity has been recently shown, with IFNγ inducing T-bet
expression and reprogramming Th2 cells upon viral infection.
As reprogramming cannot occur in the absence of TCR stimulus
in vitro, it may be concluded that cytokines alone are not
sufficient to induce this plasticity (Hegazy et al., 2010). Similar
scenarios have been observed also for other T cell subtypes
(Hirahara et al., 2013).
By measuring the expression and abundance of T-bet (Th1)
and GATA-3 (Th2) transcription factors, it is possible (i) to
monitor whether a conditioned environment influences the
appearance of a specific T cell subtype selection and, more
importantly, (ii) to determine which cytokine threshold has a
marked impact on the T cell differentiation process when using,
for example, a dilution series of conditioned media (Figure 2C).
These experiments may be performed by progressively varying
the time of cytokine administration during prolonged TCR
stimulation, to gather information about the specific time post-
stimulation at which T cells are committed to a certain lineage.
Specifically, we propose a scheme to conduct such experiments
(Figure 3). The timing and dosage of action of specific cytokines,
or conditioned media, can be varied by altering the moment of
their addition in in vitro experiments (Figure 3A). By making
dilution series, T cell differentiation can be followed as a function
of time post-cytokine administration and of cytokine dosage.
Figure 3B presents a further elaboration of the scheme, where
variable scenarios of T cell activation, differentiation and memory
may occur upon varying in time both the relative timing and
dosage of the administered pattern of cytokines.
Hence, the aim is not only to identify which definite cytokine
pattern stimulates the fate of T cell differentiation, but to
determine quantitatively the specific threshold of cytokine dosage
(concentration) and temporal constraints impinging the T cell
decision lineage. These data may serve as input as well as
validation for computer models that can temporally explore
the requirement for cytokine dosage and precise timing of
activity during the T cell differentiation process. Although genetic
engineering is not a prerequisite in this scenario, the experiments
presented in Figures 2, 3 may be of help to generate quantitative
data that may serve as inputs for computer models. T cells
expressing transcription factors tagged with fluorescent proteins
may be investigated for their lineage status through time by
quantitative, non-destructive measurement. Moreover, by using
genetic engineering technologies that allow for modulation of
the dosage of intracellular signaling components or transcription
factors, control studies on these molecules with respect to the
activation and differentiation of T cells may be investigated.
TIPPING THE BALANCE BETWEEN
CYTOKINE AND TCR DOSAGE IN
MEMORY T CELL DEVELOPMENT
Shaping the differentiation process of T cells after their activation
is mainly dependent on two cues: (i) the magnitude of TCR
activation and (ii) the pattern of cytokines available which, in
turn, largely depends on the nature of the invading pathogen. In
addition to the types of cytokines, their dosage (concentration)
also impacts the speed and magnitude of differentiation into
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FIGURE 2 | Experimental design for establishing cytokine requirement for differentiation to effector and memory T cells. (A) Several cytokines are involved in the
balance dictating T effector cell activation, which ultimately results in a lineage commitment toward Th1 or Th2 phenotypes. After differentiation, T cells may exhibit
plasticity, resulting in the ability to switch lineage commitment (dashed arrows) or to exhibit an intermediate phenotype (not shown). (B) T cells are stimulated with
antibodies triggering CD3 or CD28 to cause a skew either toward the Th1- or Th2-specific lineages. The medium may then be added to naïve T cells to investigate
whether the specific cytokines released may impact the T cell phenotype. (C) Similar experiments as in (B) can be performed by adding different doses of
conditioned medium. Phenotypic analysis for GATA-3 and T-bet reveals how T cells have differentiated in vitro. (D) T cells require a constant activation of their TCR
as well as of the appropriate pattern of cytokines to remain fully engaged during the process of antigen recognition. If the TCR is no longer activated, for example
due to loss of antigen, T cells may either undergo apoptosis or differentiate to memory T cells. The latter requires stimulation by the survival signals IL-7 and IL-15.
Typically, T cells undergoing apoptosis after an acute inflammation are less sensitive to these interleukins as compared to T cells that develop into memory T cells.
Effector T cells are assumed to have their TCR engaged, but both antigen and APC are not displayed for sake of clarity.
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FIGURE 3 | Cytokine dosage and administration timing impact T cell fate. (A) After activation, cytokines may be administered at different times and quantities
(dosage) to investigate the effects on the dynamics of T cell differentiation. Black and gray bars represent a discrete administration of variable amounts of two
different cytokines. tn represents the time at which activation of naïve T-cells takes place. (B) Similar experiment as in (A) can be performed, where cytokines
involved in different processes, such as differentiation and memory formation, are administered to T cells at different times and doses, or in a reversed order. Color
legends are used as in (A). tn represents the time at which activation of naïve T-cells takes place.
several types of effector and memory T cells. In an inflammatory
environment, IL-2, IL-12, and type I IFN are required to
unleash the full cytotoxic potential of activated CD8+ T
cells. Importantly, low concentrations of these cytokines inhibit
effector T cell formation while pushing the balance toward
memory CD8+ T cell differentiation (Pennock et al., 2013).
Activation of naïve T cells and their differentiation into
effector cells have been described as a function of antigen and
MHC recognition, co-stimulation and survival signals. However,
the relevance of several cues that stimulate CD4+ T cells to
differentiate to the memory subtype, while deleting most effector
cells, still remains debated. Mechanisms that have been proposed
to be responsible for this switch include TCR-affinity (mainly
antigen dissociation constants) (Kim et al., 2013), CD20 co-
stimulation (Dooms and Abbas, 2006), and persistence of high
expression levels of IL-2 (Dooms et al., 2007), IL-7 (Kondrack
et al., 2003), and IL-15 (Purton et al., 2007) (Figure 2D). Notably,
a crosstalk exists between TCR activation and cytokine signaling.
The TCR signaling pathway that triggers activation of naïve
T cells includes phosphorylation events through linker-adapter
molecules such as the SH2-containing phosphoprotein SLP-76
(Jordan et al., 2003). CD4+ T cells carrying inactivated SLP-
76 are unable to produce IL-7 and IL-15 upon TCR-mediated
stimulation, despite IL-receptors being functional (Bushar et al.,
2010). In line with this finding, artificial memory CD8+ T cells
have been generated by treating isolated T cells with IL-7 and IL-
15 (Cieri et al., 2013). Thus, tipping the balance between TCR and
cytokine dosage influences the fate of memory T cells.
The development of CD4+ and CD8+ T cells is distinct, with
CD4+ but not CD8+ T cells exhibiting lineage diversity. This
diversity results in a variable distribution of memory cells within
each lineage, with the distribution potentially varying due to the
uncertainty in T cells that differentiate to the memory subtype
to retain their lineage-differentiation traits (Gasper et al., 2014).
Altogether, these open questions challenge the investigation of
memory T cell formation. Although memory CD8+ T cells
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are stably maintained, the number of memory CD4+ T cells
declines over time. Thus, the effector lineage of memory CD4+ T
cells is furthermore difficult to track over time, as these display
substantial diversity and under certain conditions can change
their lineage commitment (Rosenblum et al., 2016). Furthermore,
CD4+ T cells play a crucial role in the development of memory
CD8+ T cells; it is however, not yet clear if the reverse also holds
true (Williams et al., 2006).
INTERLEUKIN AND CELL
CYCLE-MEDIATED CROSSTALK FOR
MEMORY T CELL FORMATION
An increasing body of studies indicate that during T cell
differentiation intracellular signaling cascades, such as the ones
governing growth (Delgoffe et al., 2011; Hasan et al., 2015; Pollizzi
et al., 2015, 2016; Zhang et al., 2016), metabolism (Almeida et al.,
2016; Fischer et al., 2017; Walker and McKenzie, 2017; Yong
et al., 2017) and cell cycle progression (Sicinska et al., 2003;
Veiga-Fernandes and Rocha, 2004; Tejera et al., 2013; Gu et al.,
2014; Rowell et al., 2014; Wells and Morawski, 2014; Delpoux
et al., 2017; Patel et al., 2017), may impact the T cell proliferative
capacity as well as the magnitude and duration of T cell-mediated
responses.
Among cell cycle regulators, the cyclin-dependent kinase
CDK2 and the CDK inhibitor p27Kip1 (in the following indicated
as p27) appear to be crucial in T cell differentiation by shifting the
balance between T cell activation and anergy. Specifically, CDK2-
deficient CD4+ T cells exhibit an anergic state even if CD28
co-stimulation is present (Chunder et al., 2012); conversely, p27-
deficient CD4+ T cells are activated upon TCR stimulation
alone (Jatzek et al., 2012). These findings are also supported by
early studies showing the involvement of p27 as anergy factor
(Boussiotis et al., 2000; Li et al., 2006; Rudd, 2006). Furthermore,
CD28 simulation – which leads to T cell proliferation – has
been shown to diminish p27 levels through activation of the
PKB/Akt pathway (Appleman et al., 2002) and of the SCF/Skp2
ubiquitin ligase responsible for p27 degradation (Appleman et al.,
2006). Finally, p27 has been shown to regulate differentiation
of both Th and Treg subtypes (Tsukiyama et al., 2001; Rowell
et al., 2005; Singh et al., 2010; Iglesias et al., 2013; Jatzek et al.,
2013).
This evidence indicates that p27 is a sensor of the T cell
proliferation status, i.e., differentiation versus anergy (Wells
and Morawski, 2014). We have recently proposed that the
crucial tuning of p27 abundance and dynamics, which fails
in a cancer scenario, is required for the correct progression
throughout cell cycle (Barberis and Verbruggen, 2017). Here,
we further propose that p27 acts as a timer to safeguard
not only cellular proliferation, but also T cell differentiation
by the tight regulation of its dosage and timing of activity.
Interestingly, an early study pointed out a role for p27 in
safeguarding against immune-mediated inflammation, although
using glomerulonephritis (group of diseases that injure the part
of the kidney that filters blood) as model system for inflammation
(Ophascharoensuk et al., 1998). Thus, p27 is an ideal candidate
to explore the precise timing of T cell differentiation by the
MAmTOW methodology, with a variable dosage of the regulator
possibly impinging on the appearance of a definite T cell lineage.
In vivo mice studies have shown that p27-deficiency enlarges
the size of the thymus and spleen, and increases the amount
of T cells in both naïve and activated states, by both
increasing proliferation and reducing apoptosis (Fero et al.,
1996; Nakayama et al., 1996). Further investigation has shown
that the T cell proliferative potential was not the result of an
increased expression of ‘survival’ cytokine receptors (CD127
and CD122, which sense IL-7 and IL-2, respectively), although
it cannot be excluded that a greater autocrine and paracrine
stimulation, due to an enlarged T cell number, may have
enhanced the proliferative effect caused by p27-deficiency
(Jatzek et al., 2012). No detectable difference in proliferation
between wild type and p27−/− mice was observed in naïve T
cells. However, surprisingly, memory CD4+ T cells exhibited
increased levels of CD127 in p27−/− mice as compared to wild
type and, concomitantly, a reduced apoptosis (Jatzek et al., 2012)
(Figure 4A). This effect has been attributed to the binding of
p27 to CDK, as mice expressing a variant of p27 lacking its
CDK-binding domain accumulate CD4+ T cells as compared
to wild type (Jatzek et al., 2012). Thus, pro-apoptotic and anti-
proliferative functions of p27 regulate the differentiation and
maintenance of memory CD4+ T cells, through its binding
to CDK.
The evidence presented here highlights a putative double
role of p27 in the development and differentiation of CD4+
T cells: (i) during the initial immune response, p27 inhibits
proliferation of T cells upon CD28 co-stimulation, and (ii) p27
inhibits development of memory T cells by promoting apoptosis.
The underlying molecular pathways are not entirely understood;
however, a few mechanisms have been suggested (Jatzek et al.,
2012): (i) an altered balance between the transcription factors
T-bet, leading to Th1 terminal differentiation, and Bcl-6, leading
to development of Th1 memory precursors (Oestreich et al.,
2012), and (ii) a p27-dependent downregulation of the IL-7
and IL-2/IL-15 receptors [CD127 and CD122 (Meghnem et al.,
2017), respectively], leading to a decreased expression of pro-
survival/anti-apoptotic proteins, such as Bcl-2, that promote
survival of memory T cells (Xue and Zhao, 2012) (Figure 4B).
Although a qualitative impact of p27 on CD4+
effector/memory T cells has been suggested, it remains unclear
how its intracellular levels modulate these two routes. That is,
the precise dosage at which p27 regulates the balance between T
cell subtypes is at present unknown. Two unresolved questions
are apparent: (i) Does a direct relation exist between the dosage
of cytokines, specifically IL-7 and IL-15, and the p27 intracellular
dosage in the formation and persistence of CD4+ memory T
cells?, and (ii) Does a lower intracellular p27 dosage compensate
for a reduced extracellular IL-7/IL-15 dosage?
These questions can be formed into hypotheses that are
testable based on the experimental approaches that we have
described. By generating T cell lines engineered such that they
express inducible and tunable variants of p27 and/or the IL7/15
receptor, the influence of these components on T cell fate can be
investigated. First, their expression can be measured as indicated
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FIGURE 4 | Role of the cyclin-dependent kinase inhibitor p27Kip1 in memory T cell formation. (A) Absence of p27Kip1 (p27) enhances expansion of T cells and
survival of memory T cells: in the former, its absence boosts proliferation, whereas, in the latter, it decreases apoptosis. (B) p27 may act to inhibit expression of the
receptor subunits of IL-7 and IL-15, which are required to promote memory T cell survival (left). When p27 is absent (right), consequent expression of IL-7 and IL-15
receptors may lead to the expression of anti-apoptotic proteins, such as Bcl-6, and to an enhanced memory T cell survival.
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in Figure 1C, with the genes of interest being under control of
their endogenous promoter and their expression modulated by
tetracycline induction (Barberis and Verbruggen, 2017). Second,
the effects of cytokine pattern, timing and dosage on T cell
proliferation may be tested as proposed in Figures 2, 3. Here,
expression (dosage) of p27 and/or of the IL7/IL15 receptor may
be measured during T cell differentiation and memory T cell
formation. Third, it can be determined how variation in the
expression level of p27 and/or the IL7/IL15 receptors may impact
a T cell becoming a memory T cell.
Altogether, the evidence presented here suggests that
formation of memory T cells is a quantitative, but not a
qualitative, process. The strategy described above would provide,
for the first time, new insights about the interplay between the cell
cycle machinery and T cell memory formation. The information
gathered should form a solid basis for descriptive, quantitative
models that accurately predict the role of dosage-mediated T cell
differentiation and memory T cell formation.
Importantly, the integration of computer modeling and
experimental validation requires considering the precise details
of a biological process. This approach is particularly relevant
for T cell differentiation and cell cycle control, for which
complexity is required to realize timely responses upon a
variety of input dynamic signals. The immune response
thorough TCR signaling is distributed among many components,
and computer models may be generated that analyze this
complexity and investigate the specific contribution of individual
components. Therefore, data-driven mathematical models of T
cell differentiation may be developed that predict how a change
in the stoichiometry of TCR signaling and cell cycle components
impacts on T cell dynamics. Typically, the experimental
data on which computer models are based are qualitative,
i.e., interactions and regulatory activations/inhibitions among
components. Because of the large number and complexity of
the molecular interactions involved, computer simulations of
well-parameterized mathematical models are crucial to design
informative experiments. By incorporating in the models realistic
dosage constraints – measured through experimental genetic
engineering technologies – quantitative computer models may
be generated. These data may converted to kinetic parameters,
i.e., concentration of components, which represent an input for
computer models. Computer models may in turn be employed
to predict T cell dynamics by varying dosage, which can be
then verified experimentally. Specifically, the copy number of
TCR signaling and cell cycle components may be modulated –
through tetracycline-based genetic engineering technologies – in
mammalian cell lines to investigate paths that lead to various T
phenotypes. Thus, a systematic exploration of model predictions
by using quantitative data may lead to the identification of the
precise dosage of components that are able to control T cell
dynamics timely.
CONCLUDING REMARKS
The innate and adaptive immune systems exhibit a dynamic
crosstalk with, dogmatically, innate immunity taking the initial
lead and gradually handing the defense over to its acquired
counterpart. The entire process involves a multitude of cells of
various origin and capabilities. Although the individual workings
of many immune system’s components are well understood,
it remains largely unknown how a robust immune response
emerges as a resultant from the interplay of its components and
how its fidelity and its kinetics are controlled.
Here, we have focused on the relevance of cytokine dosage for
T cell activation and differentiation, pointing out the necessity
to develop and implement experimental technologies that allow
a high degree of control of intracellular signaling components
in single-cell expression. The required experimental precision
may be achieved by employing genetic engineering technologies
such as CRISPR/Cas9, and the MAmTOW methodology that
we have recently devised (Barberis and Verbruggen, 2017). The
combination of these technologies can enable the investigation of
the precise upper and lower expression boundaries of intracellular
T cell signaling and transcription factors governing T cell
activation/differentiation, and may help to determine their degree
of control (if any) of the processes. The measurement of such
boundaries for these components will then allow for in silico
mathematical models to comprehend and predict how these
shape the activation/differentiation response of T cells, and
prevent an unwanted (premature or delayed) immune response.
Indeed, computer models of T cell differentiation may be able
to test in silico the effect of a characteristic dosage of specific
components on the timing of a T cell response.
Interestingly, other types of balance may be investigated
as well. For example, the intracellular balance between pro-
apoptotic and anti-apoptotic signals may be potentially involved
in the differentiation to memory T cells. By reducing or
lengthening the lifespan of effector T cells, the balance of
these signals allows for differentiation to memory T cells (Jay
et al., 2013). In this scenario, the relevance of the quantitative
balance between pro- versus anti-apoptotic signals, such as Bim
and Bcl-6, respectively, may be investigated. For memory T
cells, another balance may be investigated. CD4+ and CD8+
T cells can develop into two subtypes of memory cells: TEM
(T effector memory) and TCM (T central memory) cells.
The difference between these two memory T cell populations
predominantly resides in their localization, which is dictated by
the absence or presence of distinct sets of chemokine receptors
and in the produced cytokine pattern upon TCR re-stimulation
(Pepper and Jenkins, 2011; Rosenblum et al., 2016). Extensive
investigations have been mounted for memory CD4+ T cells
to investigate whether TEM/TCM formation may be lineage-
dependent. However, no clear and unambiguous relation has
been revealed yet (Pepper and Jenkins, 2011).
Finally, the integration between computer models and
experimentation has the potential to (i) identify new relationships
among different phenotypes of differentiated T cells, (ii)
elucidate the molecular mechanisms leading to the various T
differentiation lineages, and (iii) suggest specific administration
schemes (i.e., input patterns, dosage and precise timing) that
may be used in immune therapy for modulating the balance
of T cell phenotypes. Recently, we and others have illustrated
through an analysis of logical models of T cell differentiation
Frontiers in Physiology | www.frontiersin.org 12 August 2018 | Volume 9 | Article 879
fphys-09-00879 July 30, 2018 Time: 17:3 # 13
Barberis et al. Dosage-Dependent Timing of T Cell Differentiation
that lineage is a function of both input patterns and their dosage
(Martinez-Sanchez et al., 2018; Puniya et al., 2018). In particular,
our model is able to predict novel, non-canonical phenotypes of
differentiated T cells, which may play a role in the overall balance
of the immune response (Puniya et al., 2018).
FUTURE PERSPECTIVES: CELL CYCLE
CONTROL OF AUTOIMMUNITY
The integrity of the immune system can be compromised by
both intrinsic and extrinsic factors. This may then lead to a loss-
of-specificity toward the pathogen, and consequent destruction
of body’s cells. This process, called autoimmunity, may lead
to a plethora of pathologies and symptoms, widely varying in
their cause, onset and severity. The emergence of autoimmunity
is a complex process involving many and different types of
cells, effectors, antigens, and both cell-to-cell and molecular
interactions of various nature. For example, it can arise due to
(epi)genetic predisposition, or to cross-reactivity of antibodies
against invading pathogens with self antigens. Whereas in
restricted cases the provoking stimulus for autoimmunity is
known, in others it seems to arise spontaneously with no rationale
mechanism being uncovered.
Although, the human immune system functions similarly
in most individuals, it is not yet understood how inter-person
differences arise. We hypothesize that a random variability in
intra-cellular components of the immune system may translate
in its variability in function; this may be responsible for
an accidental cellular proliferation upon recognition of a self
antigen, potentially leading to an autoimmune response that
would impact the overall system’s robustness. In this context, we
speculate that the consequence of a spontaneous occurrence of
autoimmunity may be cell cycle related. Cell cycle control plays
a central role in the decision of whether T cells proliferate upon
stimulation, or whether they become unresponsive, insensitive,
and anti-proliferative, with CDK2 and p27 exerting a pivotal
role in the balance of proliferation versus anergy (Rowell et al.,
2005, 2014; Wells and Morawski, 2014). For example, to transit
to a proliferative state, T cells need to overcome arrest in the
G1 phase of the cell cycle mediated by p27 after co-stimulation
(Rudd, 2006). An abundance of p27 in a T cell recognizing an
antigen against the self may thus critically limit its proliferation
and prevent an autoimmune response. Importantly, p27 inhibits
systemic autoimmunity through the control of activity and
differentiation of Treg cells (Iglesias et al., 2013), and it has
been recognized as a sensor of the T cell proliferation status,
specifically as anergy factor (Boussiotis et al., 2000; Li et al., 2006;
Rudd, 2006; Wells and Morawski, 2014).
Within a defined cell population the expression of all proteins,
including p27, may exhibit considerable variability. This concept
is presented in Figure 5A, where expression of a protein
(supposedly p27) in two different cells - where p27 is indicated
by blue and red color, respectively for the two different cells - is
oscillating over time. The two cells have a similar periodicity and
mean expression levels of p27, but they differ in p27 expression
variability, which is indicated with lowest and highest borders
(plotted as dotted lines). In Figure 5B, a hypothetical frequency
histogram is plotted for p27 levels in both cells.
Let us hypothesize this protein being p27. The spatiotemporal
regulation of p27 has been investigated in detail experimentally,
with p27 exhibiting an oscillatory behavior throughout cell cycle
progression (Starostina and Kipreos, 2012). Specifically, p27
levels (i) are high in the G1 phase of the cell cycle, to inhibit an
earlier cyclin/Cdk2 activity and prevent an untimely entry into S
phase, and (ii) drop at the G1/S transition, to release cyclin/Cdk2
inhibition and allowing DNA replication to start (Starostina and
Kipreos, 2012). Even though a cell may not divide, the protein
concentration oscillates, due to periodical protein turnover and,
likely, also due to stochastic gene transcription. The variability in
p27 levels due to the latter aspect differs between the two cells,
being larger for the cell with p27 drawn in red color. Now, let us
suppose that a definite threshold of activation exists, which would
need to be reached before p27 level is sufficiently low to allow
cell cycle exit. This condition, under the given circumstances, is
FIGURE 5 | Variability in protein dosage impacts system’s robustness.
(A) Protein expression may oscillate over time. If the variability in protein
expression between cells increases, some cells may express a protein beyond
the boundaries of robustness (light blue area; lower). Solid (blue and red) lines
indicate the mean of protein expression in a cell population over time, whereas
dashed lines indicate cell-to-cell variability. (B) Protein expression should be
assessed at the single-cell level in order to investigate the impact of protein
variability. Both (blue and red) distributions reveal the same mean, however,
the variability of the red protein distribution may lead some cells to express it
out of the cell’s robustness boundaries.
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never met for the blue protein; hence, the cell will remain in a
state of quiescence. Conversely, the red protein may occasionally
reach the definite threshold of activation during its periodic cycle,
and will exit the cell cycle, due to the variability in stochastic gene
transcription.
Translating this scenario to the role of p27 in the immune
system, the two variable p27 protein (blue and red) levels
may be exhibited by two T cells. Let us suppose that the
definite threshold represents a critical p27 level at which the
stimulatory capacity toward the self antigens is sufficient to
provoke an unwanted T cell proliferation. The T cell carrying
the blue p27 protein will never reach this condition, as its
p27 level will be never sufficiently low to cross the threshold.
This scenario may be characteristic of a healthy individual.
A genuine antigen, however, will raise this threshold enabling
T cell proliferation. That is, the T cell carrying the red
p27 protein – that exhibits a sufficient oscillation to cross
the threshold at some time points – may prove potentially
vulnerable to proliferation upon stimulation by self antigens.
This scenario may be characteristic of an individual with an
immune disease. Although both T cells will become anergic in
most cases when self antigens are encountered, the cell with
the red p27 protein can proliferate under certain conditions,
thus potentially stimulating an immune response against the
self.
As described here for intracellular T cell signaling
components, genetic engineering technologies can be employed
to systematically measure upper and lower boundaries of gene
and/or protein dosage, to gain understanding about their impact
on autoimmunity. Thus, the gene expression ceiling may be
related to whether immune cells would be activated by a weak
stimulus or a self antigen. Practically, a fluorescent protein
controlled by the promoter of an inflammatory gene may be
used as readout for the expression level of the target protein, or
the cells may be checked for the expression of specific surface
markers. An example of an inflammatory gene that may be
tested is the transcription factor FOXP3. Maintenance of an
appropriate expression level of FOXP3 leads to the differentiation
and maturation of Treg (regulatory) cells (Hori et al., 2003),
which play important roles in immunological tolerance (Xiao
et al., 2013). Mice and humans with a loss of FOXP3 function
develop autoimmunity and inflammatory disease. Activated T
cells can transiently upregulate FOXP3 levels (Gavin et al., 2006),
and activated T cells carrying high and stable expression levels
of FOXP3 can become immunosuppressive (Wang et al., 2007).
Interestingly, crosstalk may be realized to maintain FOXP3 levels,
positively mediated by IL-2 (Fontenot et al., 2005), and negatively
regulating its stability and activity by CDK2 (Morawski et al.,
2013).
Altogether, the evidence presented in this study suggests
that an interplay of cell cycle with T cell-specific factors may
modulate T cell proliferation. A definite dosage of these factors
may determine the outcome of the delicate balance between
proliferation and anergy, and the same may apply to the
balance between immune and autoimmune response. Thus, the
MAmTOW methodology that we have recently envisioned may
be of help to investigate these delicate balances, therefore to
explore the robustness of the immune system.
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